Irish pharmaceutical storage provider Q1 Scientific has announced plans to open a new storage facility in Durham, North Carolina, US.

The “new state-of-the-art facility” will initially offer seven ICH stability chambers covering a range of conditions.

It will be situated at Durham’s Research Triangle Park (RTP), next to an analytical facility of its parent company Cambrex, with the location chosen to allow for deliveries within 48 hours across the US.

The facility is scheduled to open before the end of 2024. Subsequent to that, Q1 has already earmarked a phase 2 expansion plan to be executed within 24 months after the opening. This will be aimed at increasing the facility’s storage capacity to 20 chambers.

Tom Loewald, CEO at Cambrex, said: “We are thrilled to expand Q1 Scientific’s reach into Durham, North Carolina, enhancing our ability to serve pharmaceutical companies across North America. This investment not only broadens our footprint but also leverages Q1 Scientific’s extensive expertise in the stability storage business.”

Q1’s expansion into Durham is its third such facility globally. It complements existing facilities in Waterford, Ireland, and Liege, Belgium.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Stephen Delaney, managing director of Q1 Scientific, added: “Operating three sites globally will be a significant benefit to our customers, who can now expect faster turnaround times for the return of samples and greater temperature-controlled transport options across the US and Europe.”